o None
Entity Type
0001641489
VTV Therapeutics Inc.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 vTv Therapeutics Inc.
Jurisdiction of Incorporation/Organization
DELAWARE
 
Year of Incorporation/Organization
  o Over Five Years Ago
  x Within Last Five Years (Specify Year) 2015
  o Yet to Be Formed  



2. Principal Place of Business and Contact Information
Name of Issuer  
 vTv Therapeutics Inc.  
Street Address 1 Street Address 2
 4170 MENDENHALL OAKS PKWY  
City State/Province/Country ZIP/Postal Code Phone No. of Issuer
 HIGH POINT  NORTH CAROLINA  27265  336-841-0300 



3. Related Persons
Last Name First Name Middle Name
Holcombe Stephen
Street Address 1 Street Address 2
4170 Mendenhall Oaks Pkwy
City State/Province/Country ZIP/Postal Code
High Point NORTH CAROLINA 27265
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Howard Rudy
Street Address 1 Street Address 2
4170 Mendenhall Oaks Pkwy
City State/Province/Country ZIP/Postal Code
High Point NORTH CAROLINA 27265
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Kindler Jeffrey
Street Address 1 Street Address 2
4170 Mendenhall Oaks Pkwy
City State/Province/Country ZIP/Postal Code
High Point NORTH CAROLINA 27265
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Kozlov Hersh
Street Address 1 Street Address 2
4170 Mendenhall Oaks Pkwy
City State/Province/Country ZIP/Postal Code
High Point NORTH CAROLINA 27265
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last Name First Name Middle Name
Fry John
Street Address 1 Street Address 2
4170 Mendenhall Oaks Pkwy
City State/Province/Country ZIP/Postal Code
High Point NORTH CAROLINA 27265
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Savas Paul
Street Address 1 Street Address 2
4170 Mendenhall Oaks Pkwy
City State/Province/Country ZIP/Postal Code
High Point NORTH CAROLINA 27265
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Spiegel Noel
Street Address 1 Street Address 2
4170 Mendenhall Oaks Pkwy
City State/Province/Country ZIP/Postal Code
High Point NORTH CAROLINA 27265
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last Name First Name Middle Name
Weiner Howard
Street Address 1 Street Address 2
4170 Mendenhall Oaks Pkwy
City State/Province/Country ZIP/Postal Code
High Point NORTH CAROLINA 27265
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture   Health Care o Retailing
  Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance   Technology
  o Insurance   o Hospitals & Physicians   o Computers
  o Investing   x Pharmaceuticals   o Telecommunications
  o Investment Banking   o Other Health Care   o Other Technology
  o Pooled Investment Fund

        Travel
  o Other Banking & Financial Services o Manufacturing   o Airlines & Airports
  Real Estate   o Lodging & Conventions
  o Commercial   o Tourism & Travel Services
  o Construction   o Other Travel
  o REITS & Finance o Other
  o Residential  
  o Other Real Estate  
o Business Services  
  Energy  
  o Coal Mining  
  o Electric Utilities  
  o Energy Conservation  
  o Environmental Services  
  o Oil & Gas  
  o Other Energy  


5. Issuer Size
Revenue Range Aggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale  2019-09-27 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
   


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary)  
  

11. Minimum Investment
Minimum investment accepted from any outside investor $ 0 USD

12. Sales Compensation
Recipient Recipient CRD Number o None
   
(Associated) Broker or Dealer o None (Associated) Broker or Dealer CRD Number o None
   
Street Address 1 Street Address 2
   
City State/Province/Country ZIP/Postal Code
     
State(s) of Solicitation o All States
 
 



13. Offering and Sales Amounts
Total Offering Amount $ 10000000 USD o Indefinite
Total Amount Sold $ 2000000 USD  
Total Remaining to be Sold $ 8000000 USD o Indefinite
 
Clarification of Response (if Necessary)
 See the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on September 30, 2019.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 0


15. Sales Commissions & Finders' Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions $ 0 USD o Estimate
Finders' Fees $ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
  $ 0 USD o
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more vTv Therapeutics Charts.
vTv Therapeutics (NASDAQ:VTVT)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more vTv Therapeutics Charts.